IPP Bureau
Former VP M. Venkaiah Naidu praises Wadi Surgicals infrastructure in AMTZ, Visakhapatnam
By IPP Bureau - April 22, 2026
The plant is currently scaling towards a production capacity of nearly 3 million gloves per day
Roche’s MS drug fenebrutinib delivers striking Phase III results by cutting relapse rates by 58%
By IPP Bureau - April 22, 2026
The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints
Moderna launches late-stage trial of mRNA bird flu vaccine
By IPP Bureau - April 22, 2026
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
ENSPRYNG cuts MOGAD relapse risk by 68% in landmark Phase III trial: Roche
By IPP Bureau - April 22, 2026
The Phase III METEOROID study met its primary endpoint, with ENSPRYNG cutting the risk of a first relapse by 68% compared to placebo in adults and adolescents
Moderna wins EU approval for first combined flu & COVID shot for adults 50+
By IPP Bureau - April 22, 2026
The approval, following a positive recommendation from the European Medicines Agency’s CHMP, makes the vaccine valid across all 27 EU member states
Ultomiris shows strong interim results in Phase III IgA nephropathy trial
By IPP Bureau - April 22, 2026
IgAN is a rare, progressive kidney disease driven by abnormal IgA immune complexes that deposit in the kidneys
BioMed X launches AI-driven bispecific antibody research team in France
By IPP Bureau - April 21, 2026
The newly formed team is led by Tomabu Adjobimey, an immunologist known for his work in host-pathogen interactions and immune modulation
Freudenberg Medical launches ISO Class 5 cleanroom, 'CleanAssure'
By IPP Bureau - April 21, 2026
The cleanroom operates under stringent ISO Class 5 conditions, using ultrapure water and air systems
India Autism Center highlights inclusive residential care at ALFOC Conclave 2026
By IPP Bureau - April 21, 2026
The conclave brought together key stakeholders from across the assisted living ecosystem
Samsung Bioepis unveils promising preclinical data for novel ADC SBE303 at AACR 2026
By IPP Bureau - April 21, 2026
SBE303 targets Nectin-4, an adhesion protein overexpressed in multiple tumor types, including urothelial, lung, and breast cancers
Aster CMI Hospital launches Karnataka’s first pediatric liver ICU ‘PEARL’
By IPP Bureau - April 21, 2026
The unit is equipped with advanced monitoring systems and supported by a multidisciplinary team
HCG Cancer Hospital, Borivali hosts ROBOCAN 1.0 to advance robotic cancer surgery adoption
By IPP Bureau - April 21, 2026
Experts highlighted how robotic-assisted procedures are improving surgical precision, reducing complications, and enabling faster recovery
K J Somaiya Hospital develops 10-minute tests to bridge India’s haemophilia diagnosis gap
By IPP Bureau - April 21, 2026
These tests deliver results in 10–15 minutes at a cost of Rs 100–Rs 150, compared to conventional diagnostics which cost up to Rs 15,000
Global warming threatens health, environment and economic stability: Dr Jitendra Singh
By IPP Bureau - April 21, 2026
The Union Minister noted that heat stress contributes to a rise in both communicable diseases such as dengue and non-communicable conditions like cardiovascular disorder
NADMED forms global Scientific Advisory Board to advance redox diagnostics and precision medicine
By IPP Bureau - April 21, 2026
The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways
